Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 3 | 2021 | 124 | 0.970 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 143 | 0.960 |
Why?
|
| Protein Kinase C beta | 1 | 2021 | 16 | 0.800 |
Why?
|
| Protein Kinase C-alpha | 1 | 2021 | 27 | 0.790 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 532 | 0.610 |
Why?
|
| Spheroids, Cellular | 3 | 2017 | 31 | 0.540 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 592 | 0.500 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 150 | 0.440 |
Why?
|
| Tamoxifen | 1 | 2013 | 168 | 0.440 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2438 | 0.380 |
Why?
|
| Protein Kinase C-delta | 1 | 2010 | 26 | 0.380 |
Why?
|
| Doxorubicin | 1 | 2010 | 295 | 0.350 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2426 | 0.330 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 2903 | 0.290 |
Why?
|
| Pain Insensitivity, Congenital | 1 | 2022 | 2 | 0.220 |
Why?
|
| Hypohidrosis | 1 | 2022 | 2 | 0.220 |
Why?
|
| Phospholipase C gamma | 1 | 2022 | 15 | 0.220 |
Why?
|
| Receptor, trkA | 1 | 2022 | 14 | 0.220 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2021 | 3 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 1047 | 0.190 |
Why?
|
| MCF-7 Cells | 3 | 2017 | 106 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 176 | 0.190 |
Why?
|
| Tretinoin | 1 | 2021 | 126 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 379 | 0.170 |
Why?
|
| Mice | 4 | 2022 | 11352 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 645 | 0.160 |
Why?
|
| Trastuzumab | 1 | 2017 | 68 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 188 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 589 | 0.140 |
Why?
|
| Integrin alpha6 | 1 | 2016 | 2 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 15 | 0.140 |
Why?
|
| Prodrugs | 1 | 2016 | 46 | 0.140 |
Why?
|
| Receptor, ErbB-2 | 1 | 2017 | 223 | 0.140 |
Why?
|
| Flavonoids | 1 | 2016 | 85 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1196 | 0.130 |
Why?
|
| Animals | 5 | 2022 | 26582 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 165 | 0.130 |
Why?
|
| CD24 Antigen | 1 | 2013 | 5 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2013 | 211 | 0.110 |
Why?
|
| Cell Survival | 2 | 2017 | 969 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1041 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1578 | 0.100 |
Why?
|
| Phenotype | 2 | 2016 | 2378 | 0.100 |
Why?
|
| Mutation | 1 | 2022 | 3968 | 0.100 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2010 | 20 | 0.090 |
Why?
|
| Female | 5 | 2021 | 44533 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 93 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 54 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2022 | 615 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 114 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 322 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2010 | 444 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2360 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1384 | 0.060 |
Why?
|
| Apoptosis | 1 | 2010 | 1683 | 0.060 |
Why?
|
| Nerve Growth Factor | 1 | 2022 | 17 | 0.050 |
Why?
|
| Channelopathies | 1 | 2022 | 4 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1197 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 100 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 119 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 279 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2021 | 1106 | 0.040 |
Why?
|
| Humans | 5 | 2022 | 86644 | 0.040 |
Why?
|
| Cobalt | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 164 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 75 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 433 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1961 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 5210 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 3241 | 0.020 |
Why?
|